The mosquito-borne infectious disease malaria resulted in about 241 million clinical episodes and 627,000 deaths in 2020. In young children and pregnant women living in areas where the disease is ...

In a finding that could significantly enhance scientists’ ability to develop and test drugs and vaccines to treat the most common and lethal form of malaria, a UCSF team has identified the full ...

Please provide your email address to receive an email when new articles are posted on . Researchers said they have identified a new “hidden” life cycle of malaria parasites in the human spleen — a ...

An essential switch in the life cycle of the malaria parasite has been uncovered by researchers in England, Germany and Holland. They have established that to infect mosquitoes that transmit malaria, ...

According to the World Health Organization (WHO), in 2019, there were approximately 229 million cases of malaria around the world, of which 409,000 were fatal. Now, researchers at the Francis Crick ...

Scientists searching for new drug and vaccine targets to stop transmission of one of the world's deadliest diseases believe they are closer than ever to disrupting the life-cycle of this highly ...

It is caused by a single-celled parasite called Plasmodium, which is transmitted between people by the female Anopheles mosquito when they bite to take blood. In this new study, published in PLOS ...

Researchers have designed a drug-like compound which effectively blocks a critical step in the malaria parasite life cycle and are working to develop this compound into a potential first of its kind ...

Researchers have tracked Cryptosporidium in real time, creating a new paradigm for how the widespread parasite reproduces in a host. "We have been interested in the romantic life of the parasite ...

Despite the recent development of effective treatments, malaria is still a serious threat to 200 million people annually, and new therapies are urgently needed. Alam et al. have reported that ...

A newly revealed role of lncRNAs in the deadly malaria parasite, Plasmodium falciparum, has opened new avenues for targeted therapeutic strategies. Malaria continues to be one of the most critical ...

In 2022, the WHO hailed Novartis’ GanLum as the most promising non-artemisinin-based combination. The Swiss drugmaker ...